Peptides are widely discussed in the context of bodybuilding because some substances classified under this broad category affect hormonal signaling; others are studied for processes occurring in muscles and other tissues, and still others occur as ingredients in dietary supplements.
In online discussions, all these groups are often presented together, although they may differ significantly in terms of chemistry and pharmacology.
Evidence that a substance changes the concentration of a hormone, increases a specific body composition parameter, or affects a specific cellular pathway, It does not automatically mean that it increases skeletal muscle mass, improves strength, increases athletic performance, accelerates recovery, or has a beneficial safety profile.
Studies involving humans clearly show why these differences matter.
A randomized study on growth hormone in recreational athletes observed changes in body composition and improvements in one specific parameter related to sprinting ability. However, no significant improvement was observed in most of the other performance parameters evaluated. [1]
In another MK-677 study, also known as ibutamoren, it increased lean mass in older people, but no corresponding improvement in strength or physical function was shown.[2]
Importantly, MK-677 it is not a peptide. It is a non-peptide mimic of growth hormone and a compound that stimulates the secretion of growth hormone.
These examples show one of the most common problems associated with interpreting information about bodybuilding: The actual biological effect does not necessarily have to confirm a broader marketing or sporting claim.
Increasing lean mass does not necessarily mean the same amount of new muscle tissue is formed. Hormonal changes are not synonymous with increased strength. Improving one performance test does not necessarily improve all aspects of athletic performance.
We apply a similar principle when evaluating other claims regarding peptides. For example, in the article about peptides for weight loss We explain why changes in total body mass, fat mass, lean mass, and muscle function belong to different categories of results.
In this article, we analyze what was actually measured in the available studies on muscle and performance; the results can be reasonably generalized; and where popular claims about bodybuilding go beyond the available evidence.
Collagen peptides used in nutrition, peptide or protein hormones, and non-peptide compounds are often grouped together with peptides in the text and are clearly distinguished.
The article is educational in nature and does not contain protocols for use, information about dosages, product rankings, recommendations for combining substances, or instructions related to increasing athletic performance.
Why are peptides discussed in bodybuilding?
Definition „muscle growth peptides” It is much broader than it might initially seem.
It may refer to:
- a mixture of peptides derived from food;
- substances related to hormones;
- hormone-related factors affecting the growth hormone axis;
- experimental molecules studied for completely different biological reasons.
Since all of these substances can appear under the same search term, it is easy to reach the mistaken conclusion that evidence regarding one category confirms the effects of the others.
Collagen peptides are, for example, dietary supplements that are produced by the breakdown of collagen proteins into smaller peptide fragments.
Studies on such products usually focus on nutritional questions, often in conjunction with resistance training.
Growth hormone, on the other hand, is a protein hormone with strong physiological effects and is being studied as a pharmacological intervention.
Growth hormone releasing peptides also act at another level of hormonal regulation.
All of these topics may appear in search results for „muscle peptides,” but they do not relate to the same intervention and cannot automatically use the same evidence.
Is MK-677 a peptide?
No.
MK-677, or ibutamoren, is non-peptid mimetic of growth hormone grelina and growth hormone secretagogue.
It often appears in discussions regarding peptides because it affects the growth hormone axis. However, such common or commercial grouping does not change its chemical structure.[2]
MK-677 studies may help analyze the broader question: do hormonal changes lead to changes in body composition and physical functioning?
However, they should not be presented as direct evidence regarding peptide supplements, collagen peptides, or peptide hormones.
Therefore, the first question when evaluating a claim related to bodybuilding should not be:
„Does this peptide work?”
A better question is:
„What exactly is the substance being discussed and what evidence exists for it?”
A credible biological mechanism is only the beginning
Muscle adaptation is a complex biological process.
It includes, among others:
- mechanical load;
- turnover of muscle proteins;
- the availability of energy;
- the availability of amino acids;
- neuro-muscular adaptation;
- the reconstruction of connective tissue;
- regeneration;
- dream;
- hormonal signaling;
- numerous cellular routes.
A substance that influences one of these processes may appear promising from a biological mechanism perspective.
However, changing a single route does not confirm the full practical effect.
For example, an increase in the concentration of a growth-related hormone does not automatically mean greater hypertrophy of skeletal muscles or an increase in strength.
The body's response depends, among other things, on:
- specific intervention;
- the size and duration of exposure;
- of the studied population;
- the tissues that the substance affects;
- level of training;
- the way of eating;
- age;
- other physiological effects.
One can therefore imagine a kind of chain of evidence.
First, the substance must reach the appropriate biological system.
Then it must significantly influence the proposed route.
The biological change would later have to be reflected in a change in muscle or other relevant tissue.
If the claim concerns strength or endurance, the tissue change should then translate into a measurable functional outcome.
At the end, the potential effects should be compared with adverse effects and other safety data.
Confirmation of the first or second stage it does not automatically prove all the subsequent ones.
Therefore, the statement:
„increases growth hormone, so it builds muscle”
it is scientifically incomplete.
The hormonal change may be real, while the effect on the muscles or performance remains unproven.
Does a higher level of IGF-1 indicate better regeneration or performance?
No.
IGF-1 is a biological marker, not a direct measure of strength, regeneration or athletic performance.
The study of ibutamoren in people after a hip fracture clearly shows this difference. IGF-1 levels increased, but most functional parameters did not improve, and the study was ultimately terminated due to a safety signal.[7]
The patient population was of course completely different from that of healthy athletes, so these results should not be used to accurately assess the risk for bodybuilders.
They do, however, show an important principle:
The hormonal response in itself does not confirm a beneficial functional effect.
Nutritional supplementation and pharmacological stimulation address other questions
Nutritional and pharmacological interventions should be analyzed separately.
The nutritional study can check whether the addition of certain collagen peptides to the diet provides an additional effect during resistance training.
The study of a hormone or a compound that affects hormonal signaling, on the other hand, concerns pharmacological intervention that acts through a different mechanism and operates in a different context of safety.
A comparative group is also important.
If collagen is compared to a placebo that does not contain protein, the study answers the question:
does adding this nutritional intervention change the outcome compared to the absence of it?
However, if collagen is compared with a similar amount of another protein source, the question becomes more specific:
does the source of the protein itself lead to a different result with a more similar total protein supply?
These are not identical research questions.
A multi-component product creates another problem
A commercial „muscle peptide complex” may contain:
- peptides;
- amino acids;
- vitamins;
- plant ingredients;
- other substances.
Evidence regarding a single isolated component does not automatically confirm the effectiveness of the entire mixture.
On the other hand, if a mixture produces an effect in the study, it does not automatically mean that we know which component was responsible for it.
That is why The precise intervention used in the study is just as important as the overall category under which the product is advertised.
What exactly does „building muscle” mean?
The term seems simple, but in studies it can refer to very different results.
The study may show:
- increase in total body weight;
- increase in lean mass;
- increase in muscle thickness;
- increase in the cross-sectional area of the muscle;
- change in the size of muscle fibers;
- change in the rate of protein synthesis;
- increase in strength.
These results are related to each other, but they are not interchangeable.
If the study shows an increase in non-fat mass, it is appropriate to state that the non-fat mass has increased according to the method used.
If the imaging shows an increase in muscle thickness, this result can be described.
If strength has increased, a specific strength test should be indicated.
The broader the claim, the more evidence is needed to confirm it.
Muscle mass, strength, and sports performance are different outcomes
One of the most important principles when interpreting these studies is:
Muscle mass, lean mass, strength and sports performance are related, but they are not the same thing.
The intervention can change one parameter without a comparable change in the others.
That is why some seemingly very positive results of bodybuilding studies lead to much more limited conclusions when we look closely at the individual endpoints.
Lean mass is not synonymous with skeletal muscle
The non-fat mass and the lean body mass are often used parameters in body composition studies.
None of them directly indicates the newly formed contractile muscle tissue.
Depending on the definition and measurement method, they also include water and other tissues that do not contain fat.
A change in hydration can therefore affect the result.
This was particularly significant in a randomized study of growth hormone in recreational athletes. The researchers indicated that increased extracellular water volume was involved in the observed change in lean body mass.[1]
This does not mean that every increase in lean mass is solely water.
It does, however, show that the increase in this parameter cannot be automatically interpreted as an identical increase in new functional muscle tissue.
Can changes in water volume affect the measurement of lean mass?
Yes.
Water is part of a mass that does not contain fat.
Changes in the distribution of fluids can therefore affect the estimated lean mass.
This does not mean that all of its growth is solely due to water. It only means that more specific data are needed to determine the growth of new muscle tissue.
The measurement method is also important
DXA and bioelectrical impedance analysis estimate body composition using other physical principles and assumptions.
None of these methods should be described as a direct „counting” of newly formed muscle fibers.
Imaging, muscle biopsy, body composition measurements, and functional tests answer different questions.
Muscle growth requires proper measurement
If the claim concerns hypertrophy specifically, measurements relating directly to the muscle become particularly important.
Imaging methods can estimate:
- muscle thickness;
- the cross-sectional area;
- volume.
Muscle biopsy, on the other hand, allows the analysis of selected fibers in a small sample of tissue.
Each method provides valuable information, but it also has its own limitations.
What did the 12-week study of collagen peptides show?
In a study involving recreationally active men, the group receiving collagen showed greater increases in estimated lean body mass.
At the same time, the cross-sectional area of type II muscle fibers increased, but The difference between the groups was not statistically significant.
In both groups, the results of strength tests improved. [3]
The authors proposed that the adaptation of connective tissue could partially explain the result regarding body composition.
However, this is an interpretation, not direct evidence that the extra lean mass consisted of newly formed muscle tissue.
The study therefore provides interesting results, but does not confirm the much broader statement that collagen peptides definitively increase skeletal muscle hypertrophy.
Strength depends on more than just muscle size
The size of the muscle can affect the ability to produce strength, but strength also depends on:
- activation of the nervous system;
- recruitment of motorized units;
- coordination;
- techniques;
- knowledge of the performed movement;
- biomechanics;
- motivation;
- a specific test protocol.
The strength is therefore dependent on the task.
Improvement in the isometric leg strength test does not automatically mean the same improvement in:
- kneels;
- in a dead state;
- extraction;
- jumping;
- a movement characteristic of a specific sport.
Does a higher non-fat mass mean greater strength?
No.
The non-fat mass also includes tissues other than muscles and water.
Strength, however, depends on a number of muscular, neurological, and technical factors.
The MK-677 study illustrates this difference well: the lean mass increased, but no corresponding improvement in strength or physical function was shown. [2]
If the statement concerns force, Force must be measured directly.
In training studies, the difference between the groups is important.
Participants in training studies often become stronger simply because they exercise.
If both the group receiving the intervention being studied and the placebo group increase strength, the key question is:
Did the intervention group improve more than the control group?
Even the statement „the participants became stronger” can mislead in such a situation.
The most direct conclusion might simply be that The training program increased strength.
Sportive performance encompasses many different abilities
„Productivity” or „performance” are other broad terms.
They may include:
- sprint;
- maximum strength;
- strength;
- the ability to repeat the effort;
- height of jump;
- reaction time;
- power;
- Results characteristic of a specific discipline.
Improving one parameter does not necessarily mean an improvement in all the others.
The study of growth hormone clearly shows this problem
In a randomized study, 96 recreational athletes completed an eight-week intervention, followed by a washout period.
Researchers noted an improvement in a specific laboratory parameter related to sprinting ability.
However, most of the other performance parameters measured did not show a significant improvement.[1]
The effect regarding sprinting also did not persist after the washout period, and the authors themselves pointed to the uncertainty regarding its practical significance for athletes.[1]
Therefore, the study should not be summarized in the following way:
„Growth hormone improves athletic performance.”.
The more precise proposal is as follows:
In the conditions of this study, the intervention affected one specific laboratory parameter related to the sprint, while most of the other parameters showed no significant improvement.
Does increasing muscle size guarantee a better athletic performance?
No.
The sports result depends on the specific task and includes much more than just the size of the muscle tissue itself.
Strength, power, sprint, endurance, coordination, technique, and skills characteristic of a given discipline are different abilities.
Increasing muscle size or improving one laboratory test does not automatically lead to better results in all disciplines.
Hormonal and functional changes may proceed differently
MK-677 studies are another example.
In a study involving older adults, MK-677 improved growth hormone parameters and increased lean mass.
However, no corresponding improvement in strength or physical functioning was observed.[2]
The authors also drew attention to the limited statistical power of the study for some functional outcomes.[2]
Both information are important.
The study shows that an increase in lean mass or growth-related hormonal activity cannot be automatically presented as evidence of improved strength or function.
At the same time, it does not prove that every possible functional effect has been definitively ruled out in all populations.
Animal studies and human studies answer different questions
Animal studies can provide important information about:
- biological mechanisms;
- tissue reactions;
- potential research hypotheses.
However, this does not mean that muscle testing in animals is automatically a bodybuilding test.
The species differ in terms of:
- metabolism;
- physiology;
- load patterns;
- life expectancy;
- hormonal regulation;
- responses to experimental interventions.
Laboratory animals can also be:
- ill;
- injured;
- immobilized;
- genetically modified;
- in old age;
- subjected to conditions that do not resemble the resistance training of a healthy person.
A substance that increases muscle size in a model of injury or disease could therefore constitute an interesting biological signal.
However, it does not confirm greater hypertrophy in a healthy adult exercising strength training.
It also does not demonstrate greater strength, better sporting performance, or acceptable long-term safety.
Positive nutritional research results require maintaining the context
Some studies of collagen peptides in humans have shown potentially beneficial changes in body composition.
However, these results should remain linked to the conditions under which they were obtained.
In a randomized study of untrained middle-aged men, specific collagen peptides were analyzed during a 12-week resistance training program.
The study is completed 97 participants assigned to groups:
- collagen;
- placebo;
- exploratory group of whey proteins. [4]
A basic comparison showed a more favorable change in lean mass and fat mass in the collagen group than in the placebo group.[4]
However, an exploratory comparison of collagen with whey protein no significant statistical differences were found in these body composition results. [4]
Therefore, the study does not confirm the widespread claim that collagen is better than whey protein.
Do studies prove that collagen is better than whey protein?
Not based on the data discussed here.
In a study of untrained men, exploratory comparison of collagen with whey protein did not reveal statistically significant differences in the reported body composition parameters.[4]
In another study, which compared similar total protein amounts, replacing part of the whey protein with collagen did not provide additional benefits regarding regeneration.[6]
This does not mean that collagen has no nutritional value.
However, it means that the selected positive results should not be turned into a universal statement that collagen is superior to whey protein.
Population matters
The participants in the aforementioned study were of middle age and had not previously trained.
It cannot be assumed automatically that identical results will occur in experienced bodybuilders who have:
- years of training experience;
- another source of protein;
- another training volume;
- less potential for rapid adaptation for beginners.
Can the research on untrained men be applied to experienced bodybuilders?
Not automatically.
The level of training is an important part of the research context.
People who start resistance training often respond quickly to a new stimulus.
An experienced bodybuilder might react completely differently.
Positive results obtained in untrained individuals therefore support conclusions regarding this population, but do not guarantee the same effect in advanced athletes.
Negative results are equally important
The review of the evidence becomes unreliable if it only takes into account favorable studies.
In a randomized study involving 25 young men, In a week of performing intensive resistance exercises, collagen supplementation did not increase the measured rate of myofibrillary protein and muscle connective tissue protein synthesis compared to placebo [5].
The concentrations of amino acids in the blood changed, but the results regarding protein synthesis did not show the additional response expected based on the mechanistic hypothesis. [5]
This is an important example showing that changing the availability of a precursor or a nutritional component does not automatically lead to the expected effect at the tissue level.
In another randomized study involving 22 physically fit men A preparation containing whey protein and collagen was compared with a similar total amount of whey protein during eccentric training.
The researchers did not find an additional improvement in the assessed indicators of muscle damage or in the recovery of functional fitness after replacing part of the whey protein with collagen.[6]
These results do not prove that collagen has no nutritional role.
They show that the result depends on the specific research question.
Clinical populations are not equivalent to healthy athletes
Studies concerning:
- elderly people;
- patients after fractures;
- people with illnesses
they can provide important scientific information.
However, they do not automatically confirm the performance-enhancing effect in healthy athletes.
In a randomized study involving ibutamirone 123 elderly patients after a hip fracture an increase in IGF-1 was observed without an improvement in most parameters of functional fitness. [7]
The study was terminated earlier due to a signal of congestive heart failure in some of the participants.[7]
The result of this should not be turned into an accurate assessment of the risk for healthy bodybuilders.
The patients were elderly and recovering from a serious injury.
The study shows, however, a general principle:
A beneficial hormonal change is not sufficient to confirm a beneficial functional outcome or safety.
The training itself may explain a large part of the observed improvement.
Resistance training is one of the most important factors interfering with bodybuilding studies.
The training itself changes:
- strength;
- muscle characteristics;
- body composition.
If a participant starts a new training program simultaneously with the supplement or the substance being studied, a simple „before” and „after” comparison does not allow determining which part of the improvement is due to the substance.
That is exactly why control groups are needed.
In an ideal study:
- The training should be similar in both groups;
- compliance with the program must be documented;
- analyze the differences between the groups;
- to control important training variables.
Differences in:
- attendance;
- progression;
- selection of exercises;
- volumes;
- intensity;
- effort
they can provide an alternative explanation for the results.
Diet and other supplements also affect the result
Nutrition is of great importance for muscle adaptation.
Changes:
- the total energy supply;
- the amount of protein;
- the supply of carbohydrates;
- body mass;
- the use of other supplements
they can influence the results regardless of the intervention being studied.
If these factors are not measured or adequately balanced between groups, they become an alternative explanation.
The choice of a comparator is particularly important in protein research.
Comparing a product containing protein with a placebo without protein can show the effect of adding the product.
However, it does not have to prove that the product is better than another suitable source of protein.
Muscle pain, muscle damage, and functional regeneration are different outcomes
„Regeneration” is another term that is often used too broadly.
The person may experience less pain, while the ability to generate force remains reduced.
The blood marker associated with muscle damage may change without evidence that the tissue has been completely repaired.
Similarly, the laboratory marker may return towards the baseline value, while athletic performance remains limited.
Does less muscle pain mean full recovery?
No.
Pain is a subjective symptom.
Regeneration may also include:
- recovering strength;
- quality of traffic;
- nerve-muscular function;
- the ability to perform a specific sport activity.
Reducing pain can be a valuable result.
It should, however, remain the result regarding pain, Unless a separate study confirms faster functional regeneration.
Does the marker of muscle damage in the blood indicate faster healing?
No.
Biomarkers can provide useful information about the biological response.
However, a single laboratory result does not confirm full tissue repair or readiness for maximum effort.
A strong claim regarding regeneration requires appropriate functional results evaluated over time.
Expectations and selective reporting can distort the experiences of bodybuilders
User interactions often involve multiple simultaneous changes.
A person can start using a new product while changing:
- training volume;
- protein supply;
- the amount of calories;
- dream;
- selection of exercises;
- other substances used.
If the results improve later, it is very difficult to determine which factor was responsible for this.
Expectations can additionally influence interpretation.
The person may pay more attention to successful workouts after starting a new intervention and attribute normal fluctuations in results to it.
There is also a problem with the selective publication of experiences.
Dramatic transformations and exceptionally positive stories more often end up on the internet than:
- no noticeable effect;
- termination of use;
- adverse effects.
Can Reddit or a forum list the „best peptide for muscle”?
No.
User reports can describe their experiences, but they usually do not allow:
- verify the product's identity;
- to control the training;
- control the diet;
- to take into account other substances;
- to know the number of people without an effect;
- to learn the full number of adverse reactions.
Opinions can generate research questions.
They cannot create a credible ranking of effectiveness.
The performance signal is not a safety request
A potentially beneficial biological or functional effect does not automatically confirm safety.
A short study may detect common side effects, but it may be too small or too short to detect rare or delayed problems.
The study of growth hormone in recreational athletes was too small to draw any definitive conclusions regarding safety. [1]
In the MK-677 study in older people, among other things, the following was noted:
- decreased sensitivity to insulin;
- increase in fasting blood glucose;
- changes in appetite;
- swelling;
- muscle pain. [2]
These results apply to a specific study and population.
They should not be used as a universal safety profile for all peptides or hormonal compounds.
The general principle remains valid, however:
effectiveness and safety are separate research questions.
Product quality is a separate issue
Even if a clinical trial exists for a specific molecule, the commercially available product does not necessarily have to be equivalent to the intervention used in the trial.
In clinical studies, specific materials produced and characterized under controlled conditions are used.
A commercial or research product may differ in terms of:
- identity;
- the quantities of the substance;
- stability;
- purity;
- formulation;
- the presence of other ingredients.
The laboratory purity percentage alone does not confirm clinical equivalence.
High chromatographic purity does not automatically prove:
- the correct molecular identity;
- the correct amount;
- stability;
- sterility when required;
- absence of significant pollutants;
- suitability for use in humans.
Therefore, the evidence regarding the tested molecule cannot be automatically applied to every product bearing the same name.
Does the „research use only” designation confirm safety for athletes?
No.
Such labeling does not confirm that the product has been shown to be safe or suitable for human use.
It also does not prove that the material is equivalent to the preparation used in the clinical trial.
The commercial designation cannot replace the clinical and qualitative data regarding a specific product.
Anti-doping regulations are a separate matter
Athletes competing in competitions must also consider another, separate question:
is the substance in question banned by anti-doping regulations?
According to List of Substances and Methods Prohibited by WADA 2026, Growth hormone, certain growth hormone releasing factors, secretagogues, and appropriate growth factors are prohibited at all times.
The list includes examples such as:
- ibutamoren;
- CJC-1295;
- ipamorelin;
- several peptides that release growth hormone.
In the appropriate categories are also BPC-157 and the beta-4 thymidine derivatives.[8]
Anti-doping status However, it is not evidence of effectiveness in building muscle.
The substance may be banned, even though there is no large, controlled bodybuilding study confirming an increase in hypertrophy or strength.
On the other hand, terms such as:
- „natural”;
- „research-only”;
- „peptide-based”
they do not confirm that the substance is allowed in sports.
Are all food peptides banned in sports?
No.
„Peptide” is a very broad chemical term.
Anti-doping regulations apply to specific substances and categories, not to every peptide found in food.
Ordinary dietary peptides should not therefore be automatically identified as prohibited pharmacological substances simply because the word „peptide” appears in both cases.
Does the fact that a substance is prohibited prove that it builds muscle?
No.
Anti-doping classification and bodybuilding effectiveness are separate issues.
The substance may be banned due to pharmacology, potential performance-enhancing effects, health issues, or a link to specific biological systems without large controlled studies confirming hypertrophy in bodybuilders.[8]
What do current studies not confirm?
The analyzed evidence does not indicate a single universal answer. „the best peptide for muscle growth” nor the „best peptide for bodybuilders”.
They also do not confirm that:
- the increase in growth hormone automatically increases strength;
- increasing IGF-1 automatically improves regeneration;
- any increase in lean mass means an increase in new contractile muscle tissue;
- The result obtained in an untrained person will occur to the same extent in an experienced bodybuilder;
- the combination of several substances must produce a greater effect;
- an interesting cellular mechanism guarantees an improvement in real sports performance;
- reducing pain automatically means full recovery;
- A favorable biomarker is equivalent to an improvement in functional ability.
Are peptide combinations automatically more effective?
No.
The combination of several substances creates a new intervention.
Evidence regarding each component separately does not confirm that the combination will provide an additive or synergistic effect.
The combination can also change the safety profile.
A credible claim that the combination works better requires its direct testing with appropriate comparison groups.
How best to evaluate the claim regarding muscle growth?
The strongest approach is the analysis of controlled human studies. of exactly that intervention, of which the claim concerns.
It is worth checking:
- whether the substance is actually a peptide;
- who participated in the study;
- what training did the participants perform;
- what the control group received;
- how the muscles or body composition were measured;
- whether the strength was directly studied;
- whether real sports performance was measured;
- whether the change was greater than in the control group;
- how the diet was controlled;
- how long the examination took;
- what adverse reactions have been reported;
- what was the statistical uncertainty.
Mixed results from body composition studies, muscle biopsies, protein synthesis, and functional tests show why a single surrogate marker is not sufficient. [3] [5]
The most reliable conclusion should specify precisely:
what has changed, what was not observed, and how widely the result can be generalized.
Limitations of the available evidence
Research on peptides and bodybuilding is difficult to summarize in a single sentence, because the substances, populations, interventions, and results vary significantly.
The first problem is classification.
Collagen peptides used as dietary supplements, protein hormones, growth hormone releasing compounds, non-peptidic secretagogues such as MK-677, and experimental research substances are often placed in one category, although they constitute fundamentally different interventions.
The second limitation is the frequent use alternative results.
Hormone concentrations, lean mass, biomarkers and cellular pathways can provide valuable information, but they should not automatically replace direct measurements:
- hypertrophy of skeletal muscles;
- forces;
- regeneration;
- sports performance.
Another limitation is the level of training of the participants.
The results obtained in untrained middle-aged people, older people, patients after fractures, or recreational athletes cannot be automatically transferred to experienced resistance training athletes.
It also has significance Duration of the study.
Short-term studies may show changes in body composition or laboratory markers, but they do not answer questions about long-term performance, maintaining the effect, or safety.
It is also important choice of comparator.
Comparing a dietary supplement with a placebo without protein answers a different question than comparing it with a similar amount of another source of protein.
In the end, there remains security, which is always specific to a particular intervention.
The absence of a serious problem in a small study does not prove long-term safety.
On the other hand, a safety signal detected in a particularly sensitive population should not be automatically translated into a precise assessment of the risk for healthy athletes.
These limitations do not make the studies useless.
They simply specify, what the data can and cannot prove.
Summary
Scientific literature does not justify the treatment „muscle growth peptides” as a single, unified category of evidence.
Under this term can appear:
- nutritional collagen peptides;
- hormonal interventions;
- experimental compounds;
- non-peptide substances, such as MK-677.
Their chemical structure, biological mechanisms, evidence base, and safety profiles vary significantly.
Studies involving humans show why claims about bodybuilding should be broken down into specific results.
Growth hormone caused changes in body composition and one parameter related to sprinting, but did not show a wide improvement in most of the tested performance parameters.[1]
MK-677 increased lean mass and influenced growth-related hormonal parameters in older adults, but no corresponding improvement in strength or physical function was demonstrated. [2]
Studies of collagen peptides have yielded some beneficial results regarding body composition under certain resistance training conditions, while other controlled studies have not shown any additional effects on protein synthesis or recovery.[3][4][5][6]
These results do not have to be contradictory.
They answer various questions.
The intervention can:
- change the hormone level without improving the strength;
- increase the lean mass without proving that all the gain is new muscle tissue;
- change the biomarker without accelerating functional regeneration;
- to bring a beneficial result in untrained adults without confirmation of the same effect in experienced bodybuilders.
The most reliable interpretation should therefore be specific, not promotional.
When evaluating any claim regarding peptides and muscle growth, the most important questions are:
What specific substance was tested?
Is it really a peptide?
Who participated in the study?
What training program was used?
What did the comparison group receive?
How were muscles or body composition measured?
Were strength and endurance directly evaluated?
Was the result better than in the control group?
How long did the examination take?
What adverse reactions have been reported?
Maintaining these distinctions makes the scientific picture much more transparent.
Current research They do not indicate the one universally best peptide for bodybuilding And they do not confirm that hormonal stimulation itself automatically leads to greater muscle growth, strength, faster recovery, or better athletic performance.
The strongest conclusions remain related to the specific intervention, the population, the measurement method, and the study in which the given result was observed.
Disclaimer
The article is purely educational and scientifically informative. It does not constitute medical, bodybuilding or sports advice, information regarding the prescription of drugs, dosage or administration of substances, recommendations regarding the combination of preparations or recommendations for the use of peptides, hormones, supplements, research compounds or other substances related to improving performance.
Laboratory test results, animal studies, studies in clinical populations, in older adults, untrained participants, or recreational athletes should not be automatically interpreted as evidence of identical effects in professional athletes or experienced bodybuilders.
Changes in hormone levels, body composition, biomarkers, or laboratory tests for performance capacity should also not be considered evidence of improvement in actual sports performance unless such an effect has been directly demonstrated.
Athletes participating in competitions should additionally take into account the current anti-doping regulations applicable to their discipline and sporting organization. Regulatory classifications and lists of prohibited substances may change over time.
References
[1] Meinhardt, U., Nelson, A. E., Hansen, J. L., Birzniece, V., Clifford, D., Leung, K. C., Graham, K., & Ho, K. K. (2010). The effects of growth hormone on body composition and physical performance in recreational athletes: A randomized trial. Annals of Internal Medicine, 152(9), 568–577. 10.7326/0003-4819-152-9-201005040-00007.
[2] Nass, R., Pezzoli, S. S., Oliveri, M. C., Patrie, J. T., Harrell, F. E., Clasey, J. L., Heymsfield, S. B., Bach, M. A., Vance, M. L., & Thorner, M. O. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: A randomized trial. Annals of Internal Medicine, 149(9), 601–611. 10.7326/0003-4819-149-9-200811040-00003.
[3] Kirmse, M., Oertzen-Hagemann, V., de Marées, M., Bloch, W., & Platen, P. (2019). Prolonged collagen peptide supplementation and resistance exercise training affect body composition in recreationally active men. Nutrients, 11(5), Article 1154. 10.3390/nu11051154.
[4] Zdzieblik, D., Jendricke, P., Oesser, S., Gollhofer, A., & König, D. (2021). The influence of specific bioactive collagen peptides on body composition and muscle strength in middle-aged, untrained men: A randomized controlled trial. International Journal of Environmental Research and Public Health, 18(9), Article 4837. 10.3390/ijerph18094837.
[5] Kirmse, M., Lottmann, T. M., Volk, N. R., DE Marées, M., Holwerda, A. M., VAN Loon, L. J. C., & Platen, P. (2024). Supplementation with collagen peptide during training does not further increase connective tissue protein synthesis rates. Medicine & Science in Sports & Exercise, 56(12), 2296–2304. 10.1249/MSS.0000000000003519.
[6] Robberechts, R., Poffé, C., Ampe, N., Bogaerts, S., & Hespel, P. (2024). Partial substitution of whey for collagen peptide supplementation improves neither indices of muscle damage nor recovery of functional capacity during eccentric exercise training in fit males. International Journal of Sport Nutrition and Exercise Metabolism, 34(2), 69–78. 10.1123/ijsnem.2023-0070.
[7] Adunsky, A., Chandler, J., Heyden, N., Lutkiewicz, J., Scott, B. B., Berd, Y., Liu, N., & Papanicolaou, D. A. (2011). MK-0677 (ibutamoren mesilate) for the treatment of patients recovering from hip fracture: A multicentre, randomised, placebo-controlled phase IIb study. Archives of Gerontology and Geriatrics, 53(2), 183–189. 10.1016/j.archger.2010.10.004.
[8] World Anti-Doping Agency. (2026). The forbidden list. Retrieved September 20, 2026, from The forbidden list.